Sirolimus-associated pneumonitis, a rare but serious drug-induced lung injury, has become a great concern clinically, because of the increasing use of sirolimus (rapamycin) in patients who have been subjected to solid organ transplantation. We report sirolimus-associated pneumonitis in two women who underwent renal transplantation. At variance with previous reports, the radiological findings shown on chest radiographs and computed tomography scans of the chest in these two cases were consolidation lesions mainly with minimal interstitial abnormalities. Our reported cases highlight that awareness of various radiological findings of sirolimus-associated pneumonitis is pivotal for physicians to make early diagnosis of the disorder in patients ...
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary syndrome that is characterized by the accum...
The mTOR inhibitors (mTORi, mammalian target of rapamycin; sirolimus and everolimus) have been recen...
Background Kidney transplant recipients are at higher risk of developing pulmonary complications rel...
AbstractObjectivesReport a case of sirolimus induced granulomatous pneumonitis.BackgroundSirolimus i...
AbstractDrug induced lung diseases (DILD) are an increasingly cause of morbidity. Many drugs have be...
International audienceIntroductionSirolimus is an immunosupressant used in renal transplantation bec...
Lymphocytic alveolitis and radiologic bronchiolitis obliterans-organizing pneumonia were the key fin...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
PURPOSE: Sirolimus is a potent immunosuppressive agent used with increasing frequency in kidney tran...
Transpl Int. 2007 Mar;20(3):291-6. Pulmonary alveolar proteinosis: a rare pulmonary toxicity of s...
Background: Interstitial pneumonitis is an ill-defined side effect of sirolimus, a new immunosuppres...
PurposeTo assess the incidence and radiographic and clinical presentation of pneumonitis associated ...
AbstractLike sirolimus, everolimus is an inhibitor of mTOR (mammalian target of rapamycin), used as ...
The proliferation signal inhibitors (PSIs)-sirolimus, everolimus, and temsirolimus-have been associa...
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary syndrome that is characterized by the accum...
The mTOR inhibitors (mTORi, mammalian target of rapamycin; sirolimus and everolimus) have been recen...
Background Kidney transplant recipients are at higher risk of developing pulmonary complications rel...
AbstractObjectivesReport a case of sirolimus induced granulomatous pneumonitis.BackgroundSirolimus i...
AbstractDrug induced lung diseases (DILD) are an increasingly cause of morbidity. Many drugs have be...
International audienceIntroductionSirolimus is an immunosupressant used in renal transplantation bec...
Lymphocytic alveolitis and radiologic bronchiolitis obliterans-organizing pneumonia were the key fin...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
The use of inhibitors of the mammalian target of rapamycin (mTORi) in renal transplantation is assoc...
PURPOSE: Sirolimus is a potent immunosuppressive agent used with increasing frequency in kidney tran...
Transpl Int. 2007 Mar;20(3):291-6. Pulmonary alveolar proteinosis: a rare pulmonary toxicity of s...
Background: Interstitial pneumonitis is an ill-defined side effect of sirolimus, a new immunosuppres...
PurposeTo assess the incidence and radiographic and clinical presentation of pneumonitis associated ...
AbstractLike sirolimus, everolimus is an inhibitor of mTOR (mammalian target of rapamycin), used as ...
The proliferation signal inhibitors (PSIs)-sirolimus, everolimus, and temsirolimus-have been associa...
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary syndrome that is characterized by the accum...
The mTOR inhibitors (mTORi, mammalian target of rapamycin; sirolimus and everolimus) have been recen...
Background Kidney transplant recipients are at higher risk of developing pulmonary complications rel...